Lymphomatoid papulosis: Clinical and pathological findings in 18 patients

被引:6
作者
Fernandez-Guarino, M. [1 ]
Carrillo-Gijon, R. [2 ]
Jaen-Olasolo, P. [1 ]
机构
[1] Univ Alcala de Henares, Hosp Ramon y Cajal, Serv Dermatol, Madrid, Spain
[2] Univ Alcala de Henares, Hosp Ramon y Cajal, Serv Anat Patol, Madrid, Spain
来源
ACTAS DERMO-SIFILIOGRAFICAS | 2012年 / 103卷 / 05期
关键词
Lymphomatoid papulosis; Findings histologic; Signs and symptoms;
D O I
10.1016/j.ad.2011.08.007
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Lymphomatoid papulosis (LyP) is a CD30(+) lymphoproliferative skin disease that has been described in association with Hodgkin lymphoma. It has also been reported to progress to mycosis fungoides or cutaneous anaplastic large-cell lymphoma. Objective: To study the clinical and histologic features of LyP and response to treatment in a patient series. Materials and methods: For this retrospective, descriptive, observational study of patients with histologically confirmed LyP and sufficient follow-up data on record, we extracted histologic findings on skin biopsy, clinical presentation, clinical course, and response to treatments. Results: Eighteen patients (10 male, 8 female) were identified. Most biopsies (14/18, 78%) showed a wedge-shaped lymphocytic infiltrate with CD30(+), CD3(+), and CD56(-) cells. A type A histologic pattern was present in the biopsies of 83% of the patients. The most common presentation (83%) consisted of papules on the trunk; for 62% LyP resolved after a single episode. Twelve percent of the patients developed mycosis fungoides (mean follow-up, 7 years); no other associations were noted. Discussion: Although few series of patients with LyP have been published in recent years, the findings reported generally coincide with our observations. Conclusion: LyP is typically a CD30(+) lymphoproliferative disorder that usually runs a benign course and responds well to treatment. (C) 2011 Elsevier Espana, S.L. and AEDV. All rights reserved.
引用
收藏
页码:388 / 393
页数:6
相关论文
共 18 条
[1]   Primary and secondary cutaneous CD30+ lymphoproliferative disorders:: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment [J].
Bekkenk, MW ;
Geelen, FAMJ ;
Vader, PCV ;
Heule, F ;
Geerts, ML ;
van Vloten, WA ;
Meijer, CJLM ;
Willemze, R .
BLOOD, 2000, 95 (12) :3653-3661
[2]   Primary Cutaneous CD30(+) Lymphoproliferative Disorders [J].
Calzado-Villarreal, L. ;
Polo-Rodriguez, I. ;
Ortiz-Romero, P. L. .
ACTAS DERMO-SIFILIOGRAFICAS, 2010, 101 (02) :119-128
[3]   The same dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis [J].
Chott, A ;
Vonderheid, EC ;
Olbricht, S ;
Miao, NN ;
Balk, SP ;
Kadin, ME .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) :696-700
[4]  
Droc Claudia, 2007, Cancer Control, V14, P124
[5]   Lymphomatoid papulosis - Reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C [J].
El Shabrawi-Caelen, L ;
Kerl, H ;
Cerroni, L .
ARCHIVES OF DERMATOLOGY, 2004, 140 (04) :441-447
[6]   Three cases of lymphomatoid papulosis with a CD56+ immunophenotype [J].
Flann, Sandy ;
Orchard, Guy E. ;
Wain, E. Mary ;
Jones, Robin Russell .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (05) :903-906
[7]   T cell receptor-γ gene analysis of CD30+ large atypical individual cells in CD30+ large primary cutaneous T cell lymphomas [J].
Gellrich, S ;
Wilks, A ;
Lukowsky, A ;
Wernicke, M ;
Müller, A ;
Muche, JM ;
Fischer, T ;
Jasch, KC ;
Audring, H ;
Sterry, W .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (04) :670-675
[8]   MUM1 expression does not differentiate primary cutaneous anaplastic large-cell lymphoma and lymphomatoid papulosis [J].
Hernandez-Machin, B. ;
De Misa, R. F. ;
Montenegro, T. ;
Rivero, J. C. ;
Bastida, J. ;
Febles, C. ;
Pique, E. .
BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (03) :713-713
[9]   Treatment of lymphomatoid papialosis with imiquimod 5% cream [J].
Hughes, PSH .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) :546-547
[10]   MUM1 expression in cutaneous CD30+ lymphoproliferative disorders:: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma [J].
Kempf, W. ;
Kutzner, H. ;
Cozzio, A. ;
Sander, C. A. ;
Pfaltz, M. C. ;
Mueller, B. ;
Pfaltz, M. .
BRITISH JOURNAL OF DERMATOLOGY, 2008, 158 (06) :1280-1287